# OnCo record qing-zhou (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/qing-zhou/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "qing-zhou" ;
  schema:name "Qing Zhou"@en ;
  schema:description "Chinese thoracic oncologist behind HARMONi-2, where the PD-1/VEGF bispecific ivonescimab beat pembrolizumab head to head."@en ;
  schema:url <https://onco.cc/people/qing-zhou/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Zhou%20Q%5BAuthor%5D%20ivonescimab> ;
  onco:tag "lung", "bispecific", "china" ;
  schema:jobTitle "Chief of Pulmonary Oncology, Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital" ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/pd1/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/ivonescimab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:institutions <https://onco.cc/institutions/guangdong-provincial-peoples-hospital/>, <https://onco.cc/institutions/csco/> ;
  onco:trials <https://onco.cc/trials/harmoni-2/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-harmoni-2-lancet-2025/> ;
  schema:affiliation <https://onco.cc/institutions/guangdong-provincial-peoples-hospital/> .